Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies

Bushby, 1995, The limb girdle muscular dystrophies—proposal for a new nomenclature, Neuromuscul Disord, 4, 337, 10.1016/0960-8966(95)00005-8

Hoffman, 1987, Dystrophin: The protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4

Campbell, 1989, Association of dystrophin and an integral membrane glycoprotein, Nature, 338, 259, 10.1038/338259a0

Yoshida, 1990, Glycoprotein complex anchoring dystrophin to sarcolemma, J Biochem (Tokyo), 108, 748, 10.1093/oxfordjournals.jbchem.a123276

Ervasti, 1991, Membrane organization of the dystrophin-glycoprotein complex, Cell, 66, 1121, 10.1016/0092-8674(91)90035-W

Yoshida, 1994, Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside, Eur J Biochem, 222, 1055, 10.1111/j.1432-1033.1994.tb18958.x

Koenig, 1988, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, 53, 219, 10.1016/0092-8674(88)90383-2

Rybakova, 1996, A new model for the interaction of dystrophin with F-actin, J Cell Biol, 135, 661, 10.1083/jcb.135.3.661

Sadoulet-Puccio, 1996, Dystrophin and its isoforms, Brain Pathol, 6, 25, 10.1111/j.1750-3639.1996.tb00780.x

Sadoulet-Puccio, 1997, Dystrobrevin and dystrophin: An interaction through coiled-coil motifs, Proc Natl Acad Sci U S A, 94, 12413, 10.1073/pnas.94.23.12413

Yoshida, 2000, Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy, Hum Mol Genet, 9, 1033, 10.1093/hmg/9.7.1033

Newey, 2001, Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle, J Biol Chem, 276, 6645, 10.1074/jbc.M008305200

Mizuno, 2001, Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin, Proc Natl Acad Sci U S A, 98, 6156, 10.1073/pnas.111153298

Ahn, 1996, The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each binds to dystrophin and its relatives, J Biol Chem, 271, 2724, 10.1074/jbc.271.5.2724

Peters, 1997, Differential association of syntrophin pairs with the dystrophin complex, J Cell Biol, 138, 81, 10.1083/jcb.138.1.81

Brenman, 1996, Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alphal-syntrophin mediated by PDZ domains, Cell, 84, 757, 10.1016/S0092-8674(00)81053-3

Kameya, 1999, Alphal-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration, J Biol Chem, 274, 2193, 10.1074/jbc.274.4.2193

Grady, 1999, Role for alphadystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies, Nat Cell Biol, 1, 215, 10.1038/12034

Ibraghimov-Beskrovnaya, 1993, Human dystroglycan: Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization, Hum Mol Genet, 2, 1651, 10.1093/hmg/2.10.1651

Suzuki, 1992, Glycoproteinbinding site of dystrophin is confined to the cysteine-rich domain and the first half the carboxy-terminal domain, FEBS Lett, 308, 154, 10.1016/0014-5793(92)81265-N

Jung, 1995, Identification and characterization of the dystrophin anchoring site on beta-dystroglycan, J Biol Chem, 270, 27305, 10.1074/jbc.270.45.27305

Ibraghimov-Beskrovnaya, 1992, Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix, Nature, 355, 696, 10.1038/355696a0

Durbeej, 1998, Dystroglycan in development and disease, Curr Opin Cell Biol, 10, 594, 10.1016/S0955-0674(98)80034-3

Ervasti, 1993, A role for the dystrophinglycoprotein complex as a transmembrane linker between laminin and actin, J Cell Biol, 122, 809, 10.1083/jcb.122.4.809

Montanaro, 1999, Alphadystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability, J Cell Biol, 145, 1325, 10.1083/jcb.145.6.1325

Helbling-Leclerc, 1995, Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy, Nat Genet, 11, 216, 10.1038/ng1095-216

Bowe, 2000, The small leucinerich repeat proteglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle, J Cell Biol, 148, 801, 10.1083/jcb.148.4.801

Williamson, 1997, Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag 1-null mice, Hum Mol Genet, 6, 831, 10.1093/hmg/6.6.831

Cote, 1999, Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses, Nat Genet, 23, 338, 10.1038/15519

Kobayashi, 1998, An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy, Nature, 394, 388, 10.1038/28256

Brockington, 2001, Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan, Am J Hum Genet, 69, 1198, 10.1086/324412

Brockington, 2001, Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDCIC, Hum Mol Genet, 10, 2851, 10.1093/hmg/10.25.2851

Yoshida, 2001, Muscular dystrophy and neuronal migration disorder daused by dutations in glycosyltransferase, POMGnT1, Dev Cell, 1, 717, 10.1016/S1534-5807(01)00070-3

Grewal, 2001, Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse, Nat Genet, 28, 151, 10.1038/88865

Mathews, 1995, Phenotypic and pathologic evaluation of the myd mouse: A candidate model for facioscapulohumeral dystrophy, J Neuropathol Exp Neurol, 54, 601, 10.1097/00005072-199507000-00014

Jaeken, 2001, Congenital disorders of glycosylation: The rapidly growing tip of the iceberg, Curr Opin Neurol, 14, 811, 10.1097/00019052-200112000-00021

Ozawa, 1998, From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophymal recessive limb-girdle muscular dystrophy in the Brazilian population, Muscle Nerve, 21, 421, 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.0.CO;2-B

Bönnemann, 2000, Disorders of the sarcoglycan complex (sarcoglycanopathies), vol 18, 26

Hack, 2000, Sarcoglycans in muscular dystrophy, Microse Res Tech, 48, 167, 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T

Liu, 1999, Sarcoglycan isoforms in skeletal muscle, J Biol Chem, 274, 38171, 10.1074/jbc.274.53.38171

Straub, 1999, Epsilon-Sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex, J Biol Chem, 274, 27989, 10.1074/jbc.274.39.27989

Barresi, 2000, Expression of gamma-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex, J Biol Chem, 275, 38554, 10.1074/jbc.M007799200

Chan, 1998, Molecular organization of sarcoglycan complex in mouse myotubes in culture, J Cell Biol, 143, 2033, 10.1083/jcb.143.7.2033

Noguchi, 2000, Formation of sarcoglycan complex with differentiation in cultured myocytes, Eur J Biochem, 267, 640, 10.1046/j.1432-1327.2000.00998.x

Hagiwara, 2001, Biglycan is an extracellular scaffolding molecule of the dystrophin-associated protein complex, Neuromuscul Disord, 11, 650

Thompson, 2000, Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein, J Cell Biol, 148, 115, 10.1083/jcb.148.1.115

Crosbie, 1997, Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex, J Biol Chem, 272, 31221, 10.1074/jbc.272.50.31221

Crosbie, 1999, Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex, J Cell Biol, 145, 153, 10.1083/jcb.145.1.153

Lebakken, 2000, Sarcospan-deficient mice maintain normal muscle function, Mol Cell Biol, 20, 1669, 10.1128/MCB.20.5.1669-1677.2000

Maecker, 1997, The tetraspanin super-family: Molecular facilitators, FASEB J, 11, 428, 10.1096/fasebj.11.6.9194523

Duclos, 1998, Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice, J Cell Biol, 142, 1461, 10.1083/jcb.142.6.1461

Coral-Vazquez, 1999, Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy, Cell, 98, 465, 10.1016/S0092-8674(00)81975-3

Hack, 1999, Muscle degeneration without mechanical injury in sarcoglycan deficiency, Proc Natl Acad Sci U S A, 96, 10723, 10.1073/pnas.96.19.10723

Araishi, 1999, Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in β-sarcoglycan-deficient mice, Hum Mol Genet, 8, 1589, 10.1093/hmg/8.9.1589

Hack, 2000, Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex, J Cell Sci, 113, 2535, 10.1242/jcs.113.14.2535

Durbeej, 2000, Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limbgirdle muscular dystrophy type 2E, Mol Cell, 5, 141, 10.1016/S1097-2765(00)80410-4

Nigro, 1997, Identification of the Syrian hamster cardiomyopathy gene, Hum Mol Genet, 6, 601, 10.1093/hmg/6.4.601

Campbell, 1995, Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage, Cell, 80, 675, 10.1016/0092-8674(95)90344-5

Straub, 1992, Direct visualization of the dystrophin network on skeletal muscle fiber membrane, J Cell Biol, 119, 1183, 10.1083/jcb.119.5.1183

Yamada, 2001, Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex, Hum Mol Genet, 10, 1563, 10.1093/hmg/10.15.1563

Rando, 2001, The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies, Muscle Nerve, 24, 1575, 10.1002/mus.1192

Petrof, 1993, Dystrophin protects the sarcolemma from stresses developed during muscle contraction, Proc Natl Acad Sci U S A, 90, 3710, 10.1073/pnas.90.8.3710

Cary, 1999, Integrin-mediated signal transduction pathways, Histol Histopathol, 14, 1001

Vachon, 1997, Integrins (alpha7beta1) in muscle function and survival: Disrupted expression in merosin-deficient congenital muscular dystrophy, J Clin Invest, 100, 1870, 10.1172/JCI119716

Hodges, 1997, Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies, J Cell Sci, 110, 2873, 10.1242/jcs.110.22.2873

Burkin, 2001, Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice, J Cell Biol, 152, 1207, 10.1083/jcb.152.6.1207

Mayer, 1997, Absence of integrin a7 causes a novel form of muscular dystrophy, Nat Genet, 17, 318, 10.1038/ng1197-318

Hayashi, 1998, Mutations in the integrin a7 gene cause congenital myopathy, Nat Genet, 19, 94, 10.1038/ng0598-94

Yoshida, 1998, Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes, J Biol Chem, 273, 1583, 10.1074/jbc.273.3.1583

Okamoto, 1998, Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane, J Biol Chem, 273, 5419, 10.1074/jbc.273.10.5419

Razani, 2000, Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy, J Cell Sci, 113, 2103, 10.1242/jcs.113.12.2103

McNally, 1998, Caveolin-3 in muscular dystrophy, Hum Mol Genet, 7, 871, 10.1093/hmg/7.5.871

Sotgia, 2000, Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan: Identification of a central WW-like domain within caveolin family members, J Biol Chem, 275, 38048, 10.1074/jbc.M005321200

Crosbie, 1998, Caveolin-3 is not an integral component of the dystrophin glycoprotein complex, FEBS Lett, 427, 279, 10.1016/S0014-5793(98)00442-6

Venema, 1997, Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle: Identification of a novel caveolin scaffolding/inhibitory domain, J Biol Chem, 272, 28187, 10.1074/jbc.272.45.28187

Matsuda, 2001, The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle, Neuromuscul Disord, 11, 626

Minetti, 1998, Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy, Nat Genet, 18, 365, 10.1038/ng0498-365

Galbiati, 2000, Transgenic over-expression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype, Proc Natl Acad Sci U S A, 97, 9689, 10.1073/pnas.160249097

Sunada, 2001, Trasngenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity, Hum Mol Genet, 10, 173, 10.1093/hmg/10.3.173

Hagiwara, 2000, Caveolin-3 deficiency causes muscle degeneration in mice, Hum Mol Genet, 9, 3047, 10.1093/hmg/9.20.3047

Galbiati, 2001, Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities, J Biol Chem, 276, 21425, 10.1074/jbc.M100828200

Bashir, 1998, A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B, Nat Genet, 20, 37, 10.1038/1689

Liu, 1998, Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle musuclar dystrophy, Nat Genet, 20, 31, 10.1038/1682

Anderson, 1999, Dysferlin is a plasma membrane protein and is expressed early in human development, Hum Mol Genet, 8, 855, 10.1093/hmg/8.5.855

Matsuda, 1999, Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy, Neurology, 53, 1119, 10.1212/WNL.53.5.1119

Rizo, 1998, C2-domains, structure and function of a universal Ca2+-binding domain, J Biol Chem, 273, 15879, 10.1074/jbc.273.26.15879

Yasunaga, 1999, A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness, Nat Genet, 21, 363, 10.1038/7693

Davis, 2000, Myoferlin, a candidate gene and potential modifier of muscular dystrophy, Hum Mol Genet, 9, 217, 10.1093/hmg/9.2.217

Britton, 2000, The third human FER-1-like protein is highly similar to dysferlin, Genomics, 68, 313, 10.1006/geno.2000.6290

Bittner, 1999, Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B, Nat Genet, 23, 141, 10.1038/13770

Gallardo, 2001, Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients, Neurology, 57, 2136, 10.1212/WNL.57.11.2136

Timpl, 1994, Collagen type VI, 207

Kuo, 1997, Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen, J Biol Chem, 272, 26522, 10.1074/jbc.272.42.26522

Pfaff, 1993, Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI, Exp Cell Res, 206, 167, 10.1006/excr.1993.1134

Wiberg, 2001, Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix, J Biol Chem, 276, 18947, 10.1074/jbc.M100625200

Bonaldo, 1998, Collagen VI deficiency induces early onset myopathy in the mouse: An animal model for Bethlem myopathy, Hum Mol Genet, 7, 2135, 10.1093/hmg/7.13.2135

Mercuri, 2000, Congenital muscular dystrophy with secondary merosin deficiency and normal brain MRI: A novel entity?, Neuropediatrics, 31, 186, 10.1055/s-2000-7460

Driss, 2000, A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3, Neuromuscul Disord, 10, 240, 10.1016/S0960-8966(00)00099-7

Bushby, 1998, Abnormal merosin in adults: A new form of late onset muscular dystrophy not linked to chromosome 6q2, Brain, 121, 581, 10.1093/brain/121.4.581

Bushby, 1998, A new form of late onset muscular dystrophy not linked to chromosome 6q2, Brain, 121, 581, 10.1093/brain/121.4.581

Aravind, 1999, The fukutin protein family—of predicted enzymes modifying cell-surface molecules, Curr Biol, 9, R836, 10.1016/S0960-9822(00)80039-1

Breton, 1999, Structure/function studies of glycosyltransferases, Curr Opin Struct Biol, 9, 563, 10.1016/S0959-440X(99)00006-8

Beckmann, 1999, Workshop report: The 66th/67th ENMC sponsored workshop—the limbgirdle muscular dystrophies, Neuromuscul Disord, 9, 436, 10.1016/S0960-8966(99)00064-4

Nigro, 1996, The 5q autosomal recessive limb-girdle muscular dystrophy (LGMD 2F) is caused by a mutation in the σ-sarcoglycan gene, Nat Genet, 14, 195, 10.1038/ng1096-195

Bönnemann, 1996, Genomic screening for β-sarcoglycan mutations: Missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E), Hum Mol Genet, 5, 1953, 10.1093/hmg/5.12.1953

Eymard, 1997, Primary adhalinopathy (alpha-sarcoglycanopathy): Clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy, Neurology, 48, 1227, 10.1212/WNL.48.5.1227

Angelini, 1998, Homozygous α-sarcoglycan mutation in two siblings: One asymptomatic and one steriod responsive mild limb-girdle muscular dystrophy patient, Muscle Nerve, 21, 769, 10.1002/(SICI)1097-4598(199806)21:6<769::AID-MUS9>3.0.CO;2-5

Ginjaar, 2000, Sarcoglycanopathies in Dutch patients with autosomal receissive limb girdle muscular dystrophy, J Neurol, 247, 524, 10.1007/s004150070151

Ben Hamida, 1983, Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia, Muscle Nerve, 6, 469, 10.1002/mus.880060702

Vainzof, 1999, Sarcoglycanopathies are responsible for 68% of severe autoso-, J Neurol Sci, 164, 44, 10.1016/S0022-510X(99)00040-4

Fanin, 1997, Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations, J Med Genet, 34, 973, 10.1136/jmg.34.12.973

Angelini, 1999, The clinical spectrum of sarcoglycanopathies, Neurology, 52, 176, 10.1212/WNL.52.1.176

Prelle, 1998, Sarcoglycan deficiency in a large Italian population of myopathic patients, Acta Neuropathol (Berl), 96, 509, 10.1007/s004010050926

Melacini, 1999, Heart involvement in muscular dystrophies due to sarcoglycan gene mutations, Muscle Nerve, 22, 473, 10.1002/(SICI)1097-4598(199904)22:4<473::AID-MUS8>3.0.CO;2-5

Gnecchi-Ruscone, 1999, Cardiomyopathy in Duchenne, Becker and sarcoglycanopathies: A role for coronary dysfunction?, Muscle Nerve, 22, 1549, 10.1002/(SICI)1097-4598(199911)22:11<1549::AID-MUS10>3.0.CO;2-A

Fadic, 1996, Brief report: Deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy, N Engl J Med, 334, 362, 10.1056/NEJM199602083340604

Melacini, 2001, Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: Molecular and biochemical defects on cardiac and skeletal muscle, Transplant Proc, 33, 1596, 10.1016/S0041-1345(00)02607-5

Tsubata, 2000, Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy, J Clin Invest, 106, 655, 10.1172/JCI9224

Cohn, 2001, Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex, J Clin Invest, 107, R1, 10.1172/JCI11642

Roberds, 1994, Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy, Cell, 78, 625, 10.1016/0092-8674(94)90527-4

Bönnemann, 1995, β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex, Nat Genet, 11, 266, 10.1038/ng1195-266

Lim, 1995, β-sarcoglycan (43 DAG): Characterization and involvement in a recessive form of limb-girdle muscular dystrophy linked to chromosome 4q12, Nat Genet, 11, 257, 10.1038/ng1195-257

Noguchi, 1995, Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy, Science, 270, 819, 10.1126/science.270.5237.819

Carrie, 1997, Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D), J Med Genet, 34, 470, 10.1136/jmg.34.6.470

Duggan, 1997, Mutations in the sarcoglycan genes in patients with myopathy, N Engl J Med, 336, 618, 10.1056/NEJM199702273360904

Passos-Bueno, 1999, Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: From LGMD2A to LGMD2G, Am J Med Genet, 82, 392, 10.1002/(SICI)1096-8628(19990219)82:5<392::AID-AJMG7>3.0.CO;2-0

dos Santos, 1998, Novel mutation (Y184C) in exon 4 of the beta-sarcoglycan gene identified in a Portuguese patient: Mutations in brief no. 177. Online, Hum Mutat, 12, 214

Duclos, 1998, Beta-sarcoglycan: Genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate, Neuromuscul Disord, 8, 30, 10.1016/S0960-8966(97)00135-1

McNally, 1996, Mutations in the carboxyl-terminus of γ-sarcoglycan cause muscular dystrophy, Hum Mol Genet, 5, 1841, 10.1093/hmg/5.11.1841

Dincer, 1997, A biochemical genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey, Ann Neurol, 42, 222, 10.1002/ana.410420214

Nowak, 2000, Severe γ-sarcoglycanopathy caused by a novel missense mutation and a large deletion, Neuromuscul Disord, 20, 100, 10.1016/S0960-8966(99)00063-2

Bönnemann, 2002, Primary γ-sarcoglycanopathy (LGMD 2C): Broadening of the mutational spectrum and diagnostic value of the immunohistochemical profile, Neuromuscul Disord, 12, 273, 10.1016/S0960-8966(01)00276-0

McNally, 1996, Mild and severe muscular dystrophy caused by a single γ-sarcoglycan mutation, Am J Hum Genet, 59, 1040

Piccolo, 1996, A founder mutation in the gamma-sarcoglycan gene of gypsies possible predating their migration out of India, Hum Mol Genet, 5, 2019, 10.1093/hmg/5.12.2019

Merlini, 2000, Homogeneous phenotype of the gypsy limb-girdle MD with the gammasarcoglycan C283Y mutation, Neurology, 54, 1075, 10.1212/WNL.54.5.1075

Moreira, 1998, A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies, J Med Genet, 35, 951, 10.1136/jmg.35.11.951

Dincer, 2000, A homozygous nonsense mutation in δ-sarcoglycan in exon 3 in a case of LGMD 2F, Neuromuscul Disord, 10, 247, 10.1016/S0960-8966(00)00100-0

Carbone, 2000, Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCK-emia, Neurology, 54, 1373, 10.1212/WNL.54.6.1373

Herrmann, 2000, Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy, Hum Mol Genet, 9, 2335, 10.1093/oxfordjournals.hmg.a018926

Betz, 2001, Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease, Nat Genet, 28, 218, 10.1038/90050

Torbergsen, 1975, A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita thomsen, Acta Neurol Scand, 51, 225, 10.1111/j.1600-0404.1975.tb07603.x

Ricker, 1989, Rippling muscle disease, Arch Neurol, 46, 405, 10.1001/archneur.1989.00520400065020

Tateyama, 2002, Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy, Neurology, 58, 323, 10.1212/WNL.58.2.323

Bushby, 2000, Dysferlin and muscular dystrophy, Acta Neurol Belg, 100, 142

Aoki, 2001, Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy, Neurology, 57, 271, 10.1212/WNL.57.2.271

Fanin, 2001, Calpain-3 and dysferlin protein screening in patients with limbgirdle dystrophy and myopathy, Neurology, 56, 660, 10.1212/WNL.56.5.660

Linssen, 1997, Miyoshi-type distal muscular dystrophy: Clinical spectrum in 24 Dutch patients, Brain, 120, 1989, 10.1093/brain/120.11.1989

Argov, 2000, Muscular dystrophy due to dysferlin deficiency in Libyan Jews: Clinical and genetic features, Brain, 123, 1229, 10.1093/brain/123.6.1229

Mahjneh, 2001, Dysferlinopathy (LGMD2B): A 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations, Neuromuscul Disord, 11, 20, 10.1016/S0960-8966(00)00157-7

Miyoshi, 1986, Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy: Seventeen cases in eight families including an autopsied case, Brain, 109, 31, 10.1093/brain/109.1.31

Illa, 2001, Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype, Ann Neurol, 49, 130, 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0

Weiler, 1999, Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s), Hum Mol Genet, 8, 871, 10.1093/hmg/8.5.871

Illarioshkin, 2000, Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy, Neurology, 55, 1931, 10.1212/WNL.55.12.1931

Vilchez, 2001, Clinical variability of dysferlin myopathy in a population cluster from a founder mutation in Valencia (Spain), Neurology, 56, A209

Camacho Vanegas, 2001, Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI, Proc Natl Acad Sci U S A, 98, 7516, 10.1073/pnas.121027598

Bethlem, 1976, Benign myopathy, with autosomal dominant inheritance: A report on three pedigrees, Brain, 99, 91, 10.1093/brain/99.1.91

Jöbsis, 1996, Genetic localization of Bethlem myopathy, Neurology, 46, 779, 10.1212/WNL.46.3.779

Jöbsis, 1996, Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures, Nat Genet, 14, 113, 10.1038/ng0996-113

Speer, 1996, Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37, Hum Mol Genet, 5, 1043, 10.1093/hmg/5.7.1043

Pan, 1998, Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy, Hum Mol Genet, 7, 807, 10.1093/hmg/7.5.807

Jöbsis, 1999, Bethlem myopathy: A slowly progressive congenital muscular dystrophy with contractures, Brain, 122, 649, 10.1093/brain/122.4.649

Merlini, 1994, Bethlem myopathy: Early-onset benign autosomal dominant myopathy with contractures: Description of two new families, Neuromuscul Disord, 4, 503, 10.1016/0960-8966(94)90091-4

Pepe, 2002, Bethlem Myopathy (BETHLEM): 86th ENMC international workshop, 10–11 November 2000, Naarden, The Netherlands, Neuromuscul Disord, 12, 296, 10.1016/S0960-8966(01)00275-9

Haq, 1999, Respiratory muscle involvement in Bethlem myopathy, Neurology, 52, 174, 10.1212/WNL.52.1.174

Lamande, 1998, Reduced collagen VI causes Bethlem myopathy: A heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency, Hum Mol Genet, 7, 981, 10.1093/hmg/7.6.981

Pepe, 1999, A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy: A diagnostic approach in the mutations' screening of type VI collagen, Neuromuscul Disord, 9, 264, 10.1016/S0960-8966(99)00014-0

Lamande, 1999, Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion, J Biol Chem, 274, 21817, 10.1074/jbc.274.31.21817

Sasaki, 2000, A Bethlem myopathy Gly to Glu mutation in the von Willebrand factor A domain N2 of the collagen alpha3(VI) chain interferes with protein folding, FASEB J, 14, 761, 10.1096/fasebj.14.5.761

Lamande, 2002, Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations, J Biol Chem, 18, 1949, 10.1074/jbc.M109932200

Bushby, 1999, The limb-girdle muscular dystrophies: Diagnostic guidelines, Eur J Paediatr Neurol, 3, 53, 10.1016/S1090-3798(99)80013-0

Naom, 1998, Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy, Neuromuscul Disord, 8, 495, 10.1016/S0960-8966(98)00065-0

Gray, 2001, Secondary changes in dysferlin expression, Neuromuscul Disord, 11, 627

Piccolo, 2000, Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies, Ann Neurol, 48, 902, 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.0.CO;2-Z

Anderson, 1999, Multiplex Western blotting system for the analysis of muscular dystrophy proteins, Am J Pathol, 154, 1017, 10.1016/S0002-9440(10)65354-0

Anderson, 2000, Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies), Neuromuscul Disord, 10, 553, 10.1016/S0960-8966(00)00143-7

Stedman, 2000, Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: Alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors, Hum Gene Ther, 11, 777, 10.1089/10430340050015671

Greelish, 1999, Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector, Nat Med, 5, 439, 10.1038/7439

Bönnemann, 1997, Strength improvement on prednisone in a patient with limb-girdle muscular dystrophy 2C (primary γ-sarcoglycanopathy), Ann Neurol, 42, 531